XML 43 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments - Schedule of Cash and Marketable Securities by Significant Investment Category (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Adjusted Cost $ 60,530,000 $ 11,567,000
Unrealized Gain/(Loss) 2,787,000 3,851,000
Fair Value 63,317,000 15,418,000
Cash and Cash Equivalents 52,061,000 5,226,000
Current Marketable Securities 10,085,000 9,136,000
Investments 1,171,000 1,056,000
Level 2 [Member] | Warrant [Member]    
Adjusted Cost 700,000 700,000
Unrealized Gain/(Loss) 471,000 356,000
Fair Value 1,171,000 1,056,000
Cash and Cash Equivalents
Current Marketable Securities
Investments 1,171,000 1,056,000
Cash and Cash Equivalents [Member]    
Adjusted Cost 20,140,000 1,733,000
Unrealized Gain/(Loss)  
Fair Value 20,140,000 1,733,000
Cash and Cash Equivalents 20,140,000 1,733,000
Current Marketable Securities  
Investments  
Money Market Funds [Member] | Level 1 [Member]    
Adjusted Cost 31,921,000 3,493,000
Unrealized Gain/(Loss)  
Fair Value 31,921,000 3,493,000
Cash and Cash Equivalents 31,921,000 3,493,000
Current Marketable Securities  
Investments  
Marketable Securities [Member] | Level 1 [Member]    
Adjusted Cost 7,769,000 5,641,000
Unrealized Gain/(Loss) 2,316,000 3,495,000
Fair Value 10,085,000 9,136,000
Cash and Cash Equivalents
Current Marketable Securities $ 10,085,000 9,136,000
Investments